Arnon Elizur (A Elizur)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Protein Protein

Atopic Dermatitis

Machine Learning

Patient Reported Outcomes

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Julia E M Upton, Arnon Elizur
Target maintenance dose for peanut oral immunotherapy is 300 mg protein (or less): Pros and cons. Allergy 79 (8) (2024)
Julia E M Upton, Arnon Elizur
Target maintenance dose for peanut OIT is 300 mg protein (or less): Pros and cons. Allergy (2024)
Liat Nachshon, Joost Westerhout, W Marty Blom, Benjamin C Remington, Michael B Levy, Michael R Goldberg, Na'ama Epstein-Rigbi, Yitzhak Katz, Arnon Elizur
Sesame eliciting and safe doses in a large sesame allergic population. Allergy (2023)
Arnon Elizur, Michael Y Appel, Liat Nachshon, Michael B Levy, Na'ama Epstein-Rigbi, Yael Koren, Marie Holmqvist, Helena Porsch, Jonas Lidholm, Michael R Goldberg
Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (NUT CRACKER study). Allergy 77 (6) (2022)
Paul J Turner, Magdalena Gretzinger, Nandinee Patel, Helen Annaruth Brough, Rebecca Sharon Chinthrajah, Motohiro Ebisawa, Arnon Elizur, Jennifer J Koplin, Rachel L Peters, Natasha Purington, Anna Nowak-Wegrzyn, Sarah Saf, Hugh A Sampson, Joost Westerhout, W Marty Blom, Joseph L Baumert, Geert F Houben, Benjamin C Remington
Updated threshold dose-distribution data for sesame. Allergy 77 (10) (2022)
Na'ama Epstein-Rigbi, Michael B Levy, Liat Nachshon, Yael Koren, Yitzhak Katz, Michael R Goldberg, Arnon Elizur
Efficacy and safety of food allergy oral immunotherapy in adults. Allergy (2022)
Aharon Kessel, Ellen Bamberger, Liat Nachshon, Yossi Rosman, Ronit Confino-Cohen, Arnon Elizur
Safe administration of the Pfizer-BioNtTech COVID-19 vaccine following an immediate reaction to the first dose. Allergy 76 (11) (2021)
Na'ama Epstein-Rigbi, Michael R Goldberg, Michael B Levy, Liat Nachshon, Arnon Elizur
Quality of life of children aged 8-12 years undergoing food allergy oral immunotherapy: Child and parent perspective. Allergy 75 (10) (2020)
Arnon Elizur, M Y Appel, Liat Nachshon, M B Levy, N Epstein-Rigbi, K Golobov, M R Goldberg
NUT Co Reactivity - ACquiring Knowledge for Elimination Recommendations (NUT CRACKER) study. Allergy 73 (3) (2017)
N Epstein Rigbi, M R Goldberg, M B Levy, L Nachshon, K Golobov, Arnon Elizur
Changes in patient quality of life during oral immunotherapy for food allergy. Allergy 72 (12) (2017)